Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low- vs high-dose systemic steroids for idiopathic sudden sensorineural hearing loss and acute low-tone sensorineural hearing loss
jRCT1031210700Recruiting
- Start
- Mar 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of prednisolone in idiopathic sudden sensorineural hearing loss (ISSNHL) and Acute Low-Frequency Hearing Loss (ALFHL) (2 arms). Primary endpoint: Improvement rate of idiopathic sudden sensorineural hearing loss and acute low-tone sensorineural hearing loss. Started Mar 2022; status: recruiting.
02
Drugs
prednisolone
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)Acute Low-Frequency Hearing Loss (ALFHL)
Beyond the preview
Go deeper on jRCT1031210700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031210700.